Quarterly report · Q2
4361.TEDINET S100OO05
Period2021-12-01 → 2022-05-31
Filed2022-07-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥7.9bn | 2020-12-01 → 2021-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.9bn | 2020-12-01 → 2021-05-31 | Cons. | Net sales |
| Operating income | ¥226m | 2021-12-01 → 2022-05-31 | Cons. | Operating income |
| Operating income | ¥270m | 2020-12-01 → 2021-05-31 | Cons. | Operating income |
| Ordinary income | ¥235m | 2021-12-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥386m | 2020-12-01 → 2021-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥273m | 2020-12-01 → 2021-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥234m | 2021-12-01 → 2022-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥273m | 2020-12-01 → 2021-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥179m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥281m | 2020-12-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥195m | 2020-12-01 → 2021-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥179m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss |
| Net income | ¥195m | 2020-12-01 → 2021-05-31 | Cons. | Profit loss |
| Total assets | ¥7.8bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥7.9bn | at 2021-11-30 | Cons. | Assets |
| Total assets | ¥7.6bn | at 2021-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.4bn | at 2022-05-31 | Cons. | Liabilities |
| Total liabilities | ¥5.6bn | at 2021-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.4bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥2.3bn | at 2021-11-30 | Cons. | Net assets |
| Net assets / equity | ¥2.2bn | at 2021-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥984m | at 2022-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2021-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥984m | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2021-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2021-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥883m | at 2020-11-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥124m | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥785m | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥388m | 2020-12-01 → 2021-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥121m | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥246m | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥109m | 2020-12-01 → 2021-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥104m | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥119m | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥78m | 2020-12-01 → 2021-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥147.06 | 2021-12-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.82 | 2022-03-01 → 2022-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥230.99 | 2020-12-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥160.3 | 2020-12-01 → 2021-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.62 | 2021-03-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 30.6% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2021-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥3.9bn |
| jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥3.9bn |
| jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥211m |
| jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥19m |
| jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥19m |
| jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥15m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-05-31 | ¥3.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-05-31 | ¥3.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-05-31 | ¥226m |
| jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥3.9bn |
| jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥3.9bn |
| jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segment | segment profit | 2020-12-01 → 2021-05-31 | ¥255m |
| jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥19m |
| jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥19m |
| jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segment | segment profit | 2020-12-01 → 2021-05-31 | ¥15m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-12-01 → 2021-05-31 | ¥3.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-12-01 → 2021-05-31 | ¥3.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-12-01 → 2021-05-31 | ¥270m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 477
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01006-000PharmaceuticalProductsReportableSegmentsMember | 3927014000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01006-000RealEstateLeasingReportableSegmentMember | 18995000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 3946010000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration | 3946010000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01006-000PharmaceuticalProductsReportableSegmentsMember | 211104000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01006-000RealEstateLeasingReportableSegmentMember | 15191000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 226296000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | CurrentYTDDuration | 226296000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-07-11 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第121期第２四半期(自 2022年３月１日 至 2022年５月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)川口化学工業株式会社 | |
| Company name in english cover page | FilingDateInstant | Kawaguchi Chemical Industry Co., Ltd | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 山 田 秀 行 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都千代田区内神田２丁目８番４号(同所は登記上の本店所在地であり、実際の業務は、下記で行っております。) | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | － | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | － | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)本社事務所 埼玉県川口市領家４丁目６番42号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 048(222)5171 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)常務取締役 荻 野 幹 雄 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E01006 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 43610 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)川口化学工業株式会社 | |
| Filer name in english | FilingDateInstant | Kawaguchi Chemical Industry Co., Ltd | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2021-12-01 | |
| Current period end date | FilingDateInstant | 2022-05-31 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2022-11-30 | |
| Previous fiscal year start date | FilingDateInstant | 2020-12-01 | |
| Comparative period end date | FilingDateInstant | 2021-05-31 | |
| Previous fiscal year end date | FilingDateInstant | 2021-11-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |